Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
Grant
Overview
Affiliation
Overview
Date/time Interval
March 30, 2018 - April 1, 2018
Awarded By
Brigham and Women's Hospital
Total Award Amount
0.00
Direct Costs
0.00
Sponsor Award Id
Affiliation
Contributor
Joao De Andrade
Principal Investigator
Maria Acosta Lara
Investigator
Maria Danila MD, MSc, MSPH
Investigator
Steven Duncan
Investigator
Tejaswini Kulkarni
Investigator
Tracy Luckhardt
Investigator